Increase/Decrease in Cash: The total change in cash for the company over the given period.
Aprea Therapeutics, Inc. (APRE) had Increase/Decrease in Cash of $-8.25M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.29M |
|
$-12.60M |
|
-- |
|
$0.29M |
|
$13.52M |
|
$-13.23M |
|
$0.63M |
|
$-12.60M |
|
$-12.60M |
|
$-12.60M |
|
$-12.60M |
|
$-12.60M |
|
$-12.60M |
|
$-13.23M |
|
$-13.21M |
|
6.54M |
|
6.54M |
|
$-1.93 |
|
$-1.93 |
|
| Balance Sheet Financials | |
$15.56M |
|
$0.06M |
|
$0.37M |
|
$15.93M |
|
$2.76M |
|
-- |
|
$0.73M |
|
$3.49M |
|
$12.44M |
|
$12.44M |
|
$12.44M |
|
8.19M |
|
| Cash Flow Statement Financials | |
$-12.89M |
|
$0.00M |
|
$4.64M |
|
$22.89M |
|
$14.64M |
|
|
Increase/Decrease in Cash |
$-8.25M |
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4631.12% |
|
-4631.12% |
|
-4623.52% |
|
-4409.16% |
|
-4409.16% |
|
$-12.89M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-101.27% |
|
-101.27% |
|
-79.08% |
|
-101.27% |
|
$1.52 |
|
$-1.97 |
|
$-1.97 |
|